Result: 5 billion people can screen for multiple disease risks — at digital speed and scale.
We do this by innovating at the intersection of three key domains:
Smartphones are already in 5 billion hands, yet their cameras remain an untapped opportunity for health monitoring. Manufacturers have invested billions to make these devices ubiquitous and sensor-rich; billions more enhance camera hardware each year. Despite this, the primary application is still photography – we are redefining it for healthcare.
The human face harbors more multimodal health information than any other visible anatomic region. It concentrates dense microvasculature, cranial nerves, and ocular structures whose dynamics reflect autonomic, neurologic, cardiovascular, and inflammatory status.
Historically, the ability to detect disease signs required in vivo methods, with invasive procedures into the body.
Currently, we measure some of this information ex vivo, non-invasively, through surface-level contact on the body.
Now, we can measure vital health data contactlessly, entirely away from the body.
This progression—from invasive to less invasive to contactless—mirrors the evolution many industries have benefitted from: shifting away from the contraints of a physical paradigm. For healthcare, this shift will exponentially increase the speed and scale at which anyone, anywhere, anytime, can access critical health insights.
Our BioEngine4D biomaker platform has been independently evaluated to quantify ten (10) scientifically-established vital signs and biomarkers with ~91% accuracy — using only a smartphone.
We strategically developed our BioEngine4D platform with a specific portfolio of 10 digital biomarkers to provide orthogonal windows into the human body — spanning head to toe. Analyzing these biomarkers, combinatorially, with our DiseaseSignatures™ model further unlocks:
Our AI models emulate the centuries-old clinical workflow — observe key biomarkers, analyse them combinatorially, and infer disease risk. Our technology enables anyone with a only their smartphone with the similar access, making objective health monitoring vastly more accessible, frequent, and scalable.
| Domain | Role | Physical | Digital | Advantage |
|---|---|---|---|---|
| Anatomy | Stores Disease Signs | Blood (Sample) | Face (Scan) | Accessiblity and Convenience |
| Sensor | Measures Disease Signs | Lab Sensors | Phone Sensors | Speed and Scale |
| Processor | Analyzes Disease Signs | Human Doctor | Digital AI | Consistency and Accuracy |
Our software-only solution is delivered as a plug-and-play API/SDK that can seamlessly integrate into an enterprise’s existing mobile app on the customer’s smartphone. This allows partners to embed our biomarker measuring platform (BioEngine4D) into their existing workflows and data streams with minimal engineering effort.
Traditional clinical trials are often burdened by high costs, logistical hurdles, and protracted timelines, delaying the delivery of life-saving treatments to patients.
The BioEngine4D digital biomarker platform enables remote, precise, and continuous monitoring of scientifically-backed physiologic endpoints. It minimises subjective assessments, accelerates data capture, and strengthens data integrity — lowering costs and compressing timelines. This shift toward decentralised trials boosts participant compliance and scales efficiently across geographies.
Life insurers face challenges in accurately assessing individual risk, often relying on indirect, generalized, and self-reported data—leading to inaccuracies, fraud, and higher costs.
BioEngine4D offers a precise, data-driven approach: a 10-second smartphone video yields objective longevity insights, shrinking fraud and enabling tailored policies that boost profitability and adoption.
Health insurers struggle with accurately predicting chronic disease risk, often resulting in increased claims and higher premiums due to inefficient risk stratification.
The BioEngine4D platform empowers health insurers with a more accurate and objective method to assess disease risk. By analyzing vital signs from a quick video, our technology helps insurers identify high-risk individuals early, enabling proactive intervention strategies. This reduces healthcare costs, improves patient outcomes, and ultimately yields a more actuarially sustainable insurance model.
Current telehealth lacks real-time vitals, limiting clinical confidence. Our AI turns any smartphone into a multi-vital scanner in seconds — enriching consultations, expanding billable services, and improving outcomes.
Most wellness solutions today require new hardware to buy, ship, charge, and wear every day. With only a smartphone, our direct-to-consumer HealthySelfie app, powered by BioEngine4D, focuses on consumer wellness by measuring and monitoring 10 head-to-toe wellness indicators, providing a holistic view of well-being, surfacing important trends and patterns, and nudging users toward healthier, preventive behaviors.
BioEngine4D is a technology platform with the potential to transform health monitoring at digital speed and scale for billions of people, establishing a new paradigm in earlier disease detection and better risk prediction.
We are building a future where virtually anyone, anytime, anywhere has instant and accessible health monitoring abilities — providing better care for your health — with only the device you already hold in your hand.
